Cargando…
Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity
BACKGROUND: Metabolic syndrome and its individual components lead to wide-ranging consequences, many of which affect the central nervous system. In this study, we compared the [(18)F]FDG regional brain metabolic pattern of participants with type 2 diabetes mellitus (T2DM) and non-DM obese individual...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218076/ https://www.ncbi.nlm.nih.gov/pubmed/34181137 http://dx.doi.org/10.1186/s41824-021-00097-z |
_version_ | 1783710715379449856 |
---|---|
author | Képes, Z. Aranyi, Cs. Forgács, A. Nagy, F. Kukuts, K. Hascsi, Zs. Esze, R. Somodi, S. Káplár, M. Varga, J. Emri, M. Garai, I. |
author_facet | Képes, Z. Aranyi, Cs. Forgács, A. Nagy, F. Kukuts, K. Hascsi, Zs. Esze, R. Somodi, S. Káplár, M. Varga, J. Emri, M. Garai, I. |
author_sort | Képes, Z. |
collection | PubMed |
description | BACKGROUND: Metabolic syndrome and its individual components lead to wide-ranging consequences, many of which affect the central nervous system. In this study, we compared the [(18)F]FDG regional brain metabolic pattern of participants with type 2 diabetes mellitus (T2DM) and non-DM obese individuals. METHODS: In our prospective study, 51 patients with controlled T2DM (ages 50.6 ± 8.0 years) and 45 non-DM obese participants (ages 52.0 ± 9.6 years) were enrolled. Glucose levels measured before PET/CT examination (pre-PET glucose) as well as laboratory parameters assessing glucose and lipid status were determined. NeuroQ application (NeuroQ(TM) 3.6, Syntermed, Philips) was used to evaluate regional brain metabolic differences. [(18)F]FDG PET/CT (AnyScan PC, Mediso) scans, estimating brain metabolism, were transformed to MNI152 brain map after T1 registration and used for SPM-based group comparison of brain metabolism corrected for pre-PET glucose, and correlation analysis with laboratory parameters. RESULTS: NeuroQ analysis did not reveal significant regional metabolic defects in either group. Voxel-based group comparison revealed significantly (P(FWE)<0.05) decreased metabolism in the region of the precuneus and in the right superior frontal gyrus (rSFG) in the diabetic group as compared to the obese patients. Data analysis corrected for pre-PET glucose level showed a hypometabolic difference only in the rSFG in T2DM. Voxel-based correlation analysis showed significant negative correlation of the metabolism in the following brain regions with pre-PET glucose in diabetes: precuneus, left posterior orbital gyrus, right calcarine cortex and right orbital part of inferior frontal gyrus; whilst in the obese group only the right rolandic (pericentral) operculum proved to be sensitive to pre-PET glucose level. CONCLUSIONS: To our knowledge, this is the first study to perform pre-PET glucose level corrected comparative analysis of brain metabolism in T2DM and obesity. We also examined the pre-PET glucose level dependency of regional cerebral metabolism in the two groups separately. Large-scale future studies are warranted to perform further correlation analysis with the aim of determining the effects of metabolic disturbances on brain metabolism. |
format | Online Article Text |
id | pubmed-8218076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-82180762021-06-24 Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity Képes, Z. Aranyi, Cs. Forgács, A. Nagy, F. Kukuts, K. Hascsi, Zs. Esze, R. Somodi, S. Káplár, M. Varga, J. Emri, M. Garai, I. Eur J Hybrid Imaging Original Article BACKGROUND: Metabolic syndrome and its individual components lead to wide-ranging consequences, many of which affect the central nervous system. In this study, we compared the [(18)F]FDG regional brain metabolic pattern of participants with type 2 diabetes mellitus (T2DM) and non-DM obese individuals. METHODS: In our prospective study, 51 patients with controlled T2DM (ages 50.6 ± 8.0 years) and 45 non-DM obese participants (ages 52.0 ± 9.6 years) were enrolled. Glucose levels measured before PET/CT examination (pre-PET glucose) as well as laboratory parameters assessing glucose and lipid status were determined. NeuroQ application (NeuroQ(TM) 3.6, Syntermed, Philips) was used to evaluate regional brain metabolic differences. [(18)F]FDG PET/CT (AnyScan PC, Mediso) scans, estimating brain metabolism, were transformed to MNI152 brain map after T1 registration and used for SPM-based group comparison of brain metabolism corrected for pre-PET glucose, and correlation analysis with laboratory parameters. RESULTS: NeuroQ analysis did not reveal significant regional metabolic defects in either group. Voxel-based group comparison revealed significantly (P(FWE)<0.05) decreased metabolism in the region of the precuneus and in the right superior frontal gyrus (rSFG) in the diabetic group as compared to the obese patients. Data analysis corrected for pre-PET glucose level showed a hypometabolic difference only in the rSFG in T2DM. Voxel-based correlation analysis showed significant negative correlation of the metabolism in the following brain regions with pre-PET glucose in diabetes: precuneus, left posterior orbital gyrus, right calcarine cortex and right orbital part of inferior frontal gyrus; whilst in the obese group only the right rolandic (pericentral) operculum proved to be sensitive to pre-PET glucose level. CONCLUSIONS: To our knowledge, this is the first study to perform pre-PET glucose level corrected comparative analysis of brain metabolism in T2DM and obesity. We also examined the pre-PET glucose level dependency of regional cerebral metabolism in the two groups separately. Large-scale future studies are warranted to perform further correlation analysis with the aim of determining the effects of metabolic disturbances on brain metabolism. Springer International Publishing 2021-02-17 /pmc/articles/PMC8218076/ /pubmed/34181137 http://dx.doi.org/10.1186/s41824-021-00097-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Képes, Z. Aranyi, Cs. Forgács, A. Nagy, F. Kukuts, K. Hascsi, Zs. Esze, R. Somodi, S. Káplár, M. Varga, J. Emri, M. Garai, I. Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity |
title | Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity |
title_full | Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity |
title_fullStr | Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity |
title_full_unstemmed | Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity |
title_short | Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity |
title_sort | glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218076/ https://www.ncbi.nlm.nih.gov/pubmed/34181137 http://dx.doi.org/10.1186/s41824-021-00097-z |
work_keys_str_mv | AT kepesz glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity AT aranyics glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity AT forgacsa glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity AT nagyf glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity AT kukutsk glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity AT hascsizs glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity AT eszer glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity AT somodis glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity AT kaplarm glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity AT vargaj glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity AT emrim glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity AT garaii glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity |